Winner: Ground-breaking approach – early diagnosis of children with an ultra-orphan condition
By: Health iQ Ltd.
For: Sanofi Genzyme
We used disease registry data and KOL validation of multi-systemic symptoms, to analyse real world data in line with Information Governance rules to provide MPS I prevalence at a regional level. A separate analysis informed a remote e-detailing campaign to community and specialist paediatricians with downloadable content and direction to a microsite. This approach, using several agencies across multiple disciplines was successful in finding 3 times the average number of patients in a year, with this difficult to diagnose, ultra-rare life limiting condition.
By: The EarthWorks
The MyAsthma app is designed to help people with asthma (or those caring for someone with asthma) understand their asthma by providing contextual environmental and lifestyle information, together with data indicating the status of their asthma. By understanding potential asthma triggers such as pollen, dust, or animal hair and combining this with information on your surroundings that may be relevant, users can have a better understanding of how to manage asthma.
An industry first, The MyAsthma app is the first from pharma that has been approved as a Class 1 medical device and CE marked. It has been developed with healthcare professionals at the Nottingham Respiratory Research Unit and the University of Nottingham to ensure quality and accuracy in the information it provides.
Some of the material on these pages may be intended for viewing only by UK healthcare professionals.